Atara Biotherapeutics Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by Atara Biotherapeutics and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 334 Atara Biotherapeutics employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that Atara Biotherapeutics has purchased the following applications: Microsoft Power BI for Analytics and BI in 2016, Boomi AtomSphere for API Management, iPaaS (Integration Platform as a Service) in 2018, Amazon EC2 for Application Hosting and Computing Services in 2012 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems Atara Biotherapeutics is running and its propensity to invest more and deepen its relationship with Microsoft , Boomi , Amazon Web Services (AWS) or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing Atara Biotherapeutics revenues, which have grown to $64.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Atara Biotherapeutics intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.